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Coenzyme Q deficiency causes impairment of the
sulfide oxidation pathway
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Abstract
Coenzyme Q (CoQ) is an electron acceptor for sulfide-quinone
reductase (SQR), the first enzyme of the hydrogen sulfide oxidation
pathway. Here, we show that lack of CoQ in human skin fibroblasts
causes impairment of hydrogen sulfide oxidation, proportional to
the residual levels of CoQ. Biochemical and molecular abnormalities
are rescued by CoQ supplementation in vitro and recapitulated by
pharmacological inhibition of CoQ biosynthesis in skin fibroblasts
and ADCK3 depletion in HeLa cells. Kidneys of Pdss2kd/kd mice, which
only have ~15% residual CoQ concentrations and are clinically
affected, showed (i) reduced protein levels of SQR and downstream
enzymes, (ii) accumulation of hydrogen sulfides, and (iii) glutathione
depletion. These abnormalities were not present in brain, which
maintains ~30% residual CoQ and is clinically unaffected. In Pdss2kd/
kd mice, we also observed low levels of plasma and urine thiosulfate
and increased blood C4-C6 acylcarnitines. We propose that impair-
ment of the sulfide oxidation pathway induced by decreased levels
of CoQ causes accumulation of sulfides and consequent inhibition of
short-chain acyl-CoA dehydrogenase and glutathione depletion,
which contributes to increased oxidative stress and kidney failure.
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Introduction
Coenzyme Q (CoQ), or ubiquinone, is a lipid antioxidant and elec-
tron carrier, present in all cell membranes, and involved in many
biological processes (Bentinger et al, 2010). Mutations in genes
encoding proteins involved in CoQ biosynthesis cause primary CoQ
deficiency, an autosomal recessive mitochondrial disorder associ-
ated with five major clinical phenotypes: (i) encephalomyopathy,
(ii) severe infantile multi-systemic disease, (iii) cerebellar ataxia,
(iv) isolated myopathy, and (v) steroid-resistant nephrotic
syndrome (Desbats et al, 2015). This heterogeneity in the clinical
presentation suggests that multiple pathomechanisms may exist.
Because of its essential function as electron carrier from mitochon-
drial complexes I and II to complex III as well as an endogenous
antioxidant, the effects of CoQ deficiency on mitochondrial bioener-
getics and oxidative stress have been assessed in vitro (Lopez et al,
2014) and in vivo (Licitra & Puccio, 2014). Increased oxidative stress
and ATP depletion have been described as initial events promoting
mitochondrial-mediated apoptotic cell death (Lopez et al, 2014)
and/or autophagy (Rodriguez-Hernandez et al, 2009).
CoQ-deficient fission yeast have been shown to produce high sul-
fide levels (Zhang et al, 2008), and more recently, proteomics stud-
ies revealed decreased protein levels of SQR in CoQ-deficient mice
carrying a missense mutation in COQ9, a protein involved in the
biosynthesis of CoQ through regulation of the levels of the hydroxy-
lase COQ7 (Lohman et al, 2014; Luna-Sa´nchez et al, 2015).
However, whether the H2S metabolism is impaired in CoQ defi-
ciency, and whether H2S metabolism impairment has a role in the
pathogenesis or the progression of this disorder, has not yet been
investigated.
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Sulfide (H2S) is a gas modulator (like nitric oxide and carbon
monoxide) produced endogenously via the cysteine catabolism
by the cytoplasmic enzymes cystathionine-b-synthase (CBS),
cystathionine-c-lyase (CSE, CTH), and 3-mercaptopyruvate by
3-mercaptopyruvate sulfurtransferase (3-MST). CBS is predomi-
nantly active in the nervous system, kidney, and liver; CSE in liver,
intestine, smooth muscle, and pancreas (Stipanuk & Beck, 1982;
Hosoki et al, 1997; Zhao et al, 2001; Enokido et al, 2005; Tiranti &
Zeviani, 2013; Gao et al, 2015), and 3-MST, a mitochondrial and
cytoplasmic enzyme, is active mainly in the nervous system (in
particular cerebellum), kidney, and vascular endothelium, where it
exerts an important cytoprotective role (Steegborn et al, 1999;
Shibuya et al, 2009, 2013).
H2S physiologically modifies cysteine residues in numerous
proteins by S-sulfhydration, affecting their functions (Mustafa et al,
2009), and it is involved in several physiological functions such as
neural development, angiogenesis, cardioprotection, prevention of
oxidative stress, cell proliferation, and apoptosis (Bouillaud &
Blachier, 2011). However, if accumulated in the order of micromolar
concentrations, it becomes toxic through interaction with heme-
containing proteins, causing severe cytochrome c oxidase (COX,
complex IV) deficiency, through rapid heme a inhibition that main-
tains the complex in a constant reduced state and accelerates long-
term degradation of COX subunits (Di Meo et al, 2011). In addition,
sulfide inhibits the enzymatic activity of short-chain acyl-CoA dehy-
drogenase (SCAD), causing dicarboxylic aciduria (Pedersen et al,
2003), and is implicated in vasorelaxation by opening ATP-sensitive
K+ channels in vascular smooth muscle (Yang et al, 2008),
inflammation (Yang et al, 2013), and reactive oxygen species (ROS)
production (Eghbal et al, 2004).
H2S is catabolized in the mitochondria by the cooperation of at
least four proteins, which sequentially perform the oxidation of the
sulfide into a sulfate ion (Fig 1). In the first step of sulfide catabo-
lism, sulfide-quinone reductase (SQR), an enzyme bound to the
Figure 1. Mitochondrial H2S oxidation pathway.
SQR converts sulfide into thiosulfate by transferring two electrons from the H2S oxidation to ubiquinone (CoQ). Thiosulfate is then converted into sulfite by TST and ETHE1;
this reaction requires a sulfur acceptor (glutathione, GSH). Excess of sulfite is converted into sulfate by SUOX.
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inner mitochondrial membrane, which belongs to the family of
flavoprotein disulfide oxidoreductases, transfers sulfane sulfur
atoms from the toxic sulfides to free sulfites, generating thiosulfate.
During this reaction, electrons are shuttled from sulfide to the mito-
chondrial electron transport chain by reduction of ubiquinone
(CoQ) to ubiquinol (Jackson et al, 2012). The product of this reac-
tion, thiosulfate, is then oxidized in the mitochondrial matrix by a
sulfurtransferase (TST, Rodhanese). TST mediates the conversion of
thiosulfate to sulfite, transferring sulfane sulfur to a –SH-containing
acceptor, like glutathione (GSH). The sulfur dioxygenase ethyl-
malonic encephalopathy protein 1 (ETHE1 or persulfide dioxyge-
nase), a mitochondrial matrix protein, participates in the conversion
of thiosulfate to sulfite. The terminal component of this known
pathway is the sulfide oxidase SUOX, which oxidizes sulfite to
sulfate, which is subsequently secreted into the blood and elimi-
nated through the urine (Muller et al, 2004; Hildebrandt & Grie-
shaber, 2008).
So far, molecular defects in ETHE1 and SUOX, responsible for
autosomal recessive ethylmalonic encephalopathy (EE) and sulfite
oxidase deficiency (or sulfocysteinuria), respectively, and the rare
molybdenum cofactor deficiency, are the only cause of sulfide meta-
bolism impairment associated with human diseases (Johnson et al,
2002; Tiranti et al, 2009).
Here, we show that in human fibroblasts, mutations in CoQ
biosynthetic genes reduce SQR levels and biochemical activity
proportionally to CoQ levels, followed by compensatory up-regula-
tion of enzymes of the downstream pathway. Biochemical and
molecular abnormalities are partially reverted by CoQ supplementa-
tion in vitro and recapitulated by pharmacologic inhibition of CoQ
biosynthesis in wild-type skin fibroblasts and by depletion in HeLa
cells of ADCK3, an atypical protein kinase involved in CoQ biosyn-
thesis regulation (Stefely et al, 2015). In contrast, in kidneys, the
only affected organ of Pdss2kd/kd mice, a mouse model of CoQ defi-
ciency, severely reduced SQR levels are associated with down-
regulation of all the downstream enzymes of the pathway, GSH
depletion, and reduction of thiosulfates. Furthermore, accumulation
of H2S in Pdss2
kd/kd mice causes short-chain CoA dehydrogenase
(SCAD) inhibition, as shown by increased blood levels of C4-C6
acylcarnitines. The shutdown of the H2S oxidation pathway
observed in kidneys of Pdss2kd/kd mice was reproduced by severe
knockdown of SQR in HeLa cells. Taken together, these findings
demonstrate multiple downstream effects of CoQ deficiency on
sulfide metabolism.
Results
CoQ10 levels are variably reduced in CoQ10-deficient
patient fibroblasts
To evaluate the possible relationship between CoQ10 deficiency and
impairment of the hydrogen sulfide oxidation pathway, we
measured CoQ10 levels in human skin fibroblasts from patients
carrying molecular defects in different genes encoding proteins
involved in the CoQ biosynthesis (COQ genes; Table 1 and Fig 2).
Patient skin fibroblasts showed variable levels of CoQ10 deficiency
ranging from 52 to 54% of normal (P1 and P5) to 28.9% (P2), and
18 and 13.4% (P3 and P4), confirming previous published findings
in the same cell lines (Table 1). Intermediates of CoQ10 biosynthe-
sis were not detected in the chromatograms of any of the patients.
Reduction in complex II-driven ADP-dependent respiration in
patient fibroblasts was consistent with their levels of CoQ10
(Appendix Fig S1A and B).
SQR activity in CoQ10-deficient patient fibroblasts is affected
without compromising complex IV activity
In order to assess sulfide oxidation in primary human CoQ10 deficien-
cies, we evaluated oxygen consumption in the presence of NaHS, a
hydrogen sulfide donor, in permeabilized human fibroblasts from
patients with CoQ10 deficiency (P1–P5). Complex I inhibitor rotenone
and the uncoupler FCCP were used to inhibit endogenous respiration
and to ensure a maximal oxidation rate, respectively. Infusion of
60 lM NaHS allowed oxygen consumption by permeabilized cells,
through the SQR-CoQ10 system, which was blocked by antimycin, an
Table 1. Summary of molecular defects and CoQ10 levels in
fibroblasts of patients studied.
Cell line
Molecular
defect Gene
CoQ10
(lg/g
protein)a References
Controls
(N = 6)
63.14  14
P1 Q167LfsX36
homozygous
ADCK3 36.9  6.5 Lagier-Tourenne
et al (2008)
P2 Q322X, S382L PDSS2 18.3  1 Lopez et al
(2006)
P3 S109N
homozygous
COQ2 11.4  0.7 Scalais et al
(2013)
P4 A302V
homozygous
COQ2 8.5  0.48 Jakobs et al
(2013)
P5 R145G
homozygous
COQ4 40.8  5.6 Brea-Calvo
(2015)
aMean  SD.
Figure 2. Schematic representation of CoQ biosynthesis showing the
molecular defects in patient fibroblasts (P1–P5).
The isoprene tail is synthesized from farnesyl pyrophosphate by PDSS1/PDSS2
and condensed to the 4HB ring by COQ2. The ring is processed into CoQ by
COQ3-7. ADCK3/CABC1 (COQ8) regulates CoQ biosynthesis through
phosphorylation of COQ3, COQ5, and COQ7.
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inhibitor of the mitochondrial respiratory chain complex III. Figure 3A
(solid lines) shows representative experiments of SQR-driven respira-
tion for each cell line. In contrast, the complex IV-driven oxygen
consumption rate was evaluated under the same conditions using
TMPD/ascorbate, instead of NaHS, as substrates (Appendix Fig S2).
The maximal respiration rate of complex IV was used to normalize
sulfide oxidation values. As expected, while complex IV-driven
oxygen consumption was comparable in all the tested cell lines
(Appendix Fig S2), CoQ10 depletion caused a significant impairment
of SQR-driven respiration in comparison with control fibroblasts,
which correlated well with the residual amount of CoQ10 (Table 1).
Fibroblasts from patients P2, P3, and P4 with a residual CoQ concen-
tration below 30% showed a larger decrease in sulfide oxidation,
while fibroblasts from patients P1 and P5 with a residual CoQ concen-
tration of ~50% only showed a partial decrease in SQR-driven respira-
tion (Fig 3A and B). Interestingly, after an initial linear decline, we
observed a progressive decrease in SQR-driven oxygen consumption
in patient-derived cells. This phenomenon could be explained by the
reduced ability of CoQ-deficient fibroblasts to oxidize sulfide, which
subsequently accumulates in the reaction media and gradually inhi-
bits complex IV activity.
To assess whether exogenous CoQ10 can restore the ability of
CoQ10-deficient fibroblasts to oxidize sulfide, fibroblasts of patients
P3, P4, and P5 were cultured 1 week in the presence of 5 lM of
CoQ10, before Oxygraph analysis was performed (Fig 3A, dashed
lines). While control cells did not show a significant increase in sul-
fide oxidation rate, COQ-mutant fibroblasts showed a significant
increase in SQR-driven respiration (Fig 3B). These data confirm that
CoQ10 is the electron acceptor essential for SQR activity and that
human primary CoQ10 deficiency causes impairment of sulfide
oxidation.
SQR protein levels in CoQ10-deficient fibroblasts are reduced
proportionally to the level of CoQ10 deficiency, and the
downstream enzymes of the H2S oxidation pathway
are up-regulated
To understand whether a reduction in SQR activity in skin fibro-
blasts is associated with a modification of SQR protein levels, we
performed Western blot in fibroblasts from patients P1 to P4. We
found that SQR protein levels were significantly decreased in the
two cell lines with lower CoQ10 levels (P3 and P4; 26.6 and 25.5%
A
B
Figure 3. Sulfide respiration in fibroblasts.
A Representative traces showing SQR-driven oxygen consumption in 3 × 106 control (C) and five patient fibroblast lines (P1–P5) in the absence (solid traces) or presence
(dashed traces) of CoQ10 in the culture medium. See Materials and Methods for the role and concentration of the compounds used. Dig = digitonin, Rot = rotenone,
fccp = carbonylcianide-p-trifluoromethoxyphenylhydrazone, Ant = antimycin, NaHS = sodium hydrosulfide.
B Relative rates of SQR-driven oxygen consumption are normalized to CIV respiration rates. Error bars represent SDs of two experiments. Two-tailed Student’s t-test.
* indicates a value of P < 0.05, ** indicates a value of P < 0.01, and *** indicates a value of P < 0.001.
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of controls; P = 0.0003; Fig 4A and B). SQR protein levels were also
partially decreased in P2 (70.9% of controls; P = 0.092), but not
in P1.
To investigate the consequences of reduced SQR activity/protein
levels on the other mitochondrial enzymes of the H2S oxidation
pathway, we measured protein levels of TST, ETHE1, and SUOX and
found them to be increased in fibroblasts from patients P1–P4 (TST:
188–489% of controls; SUOX: 159–355% of controls; and ETHE1:
255% of controls in P4; for TST: P = 0.16, P = 0.0115, P = 0.097,
P = 0.0115; for SUOX: P = 0.014, P = 0.007, P = 0.007, P = 0.007;
for ETHE1: P = 0.37, P = 0.076, P = 0.83, P = 0.002; Fig 4C–E).
To assess whether exogenous CoQ10 was able to restore SQR
protein levels, we cultured the two cell lines with lower CoQ10 and
SQR levels (P3, with 49% of residual SQR, P = 0.006, and P4, with
39% residual SQR, P = 0.006) with 5 lM of CoQ10 for 1 week. We
observed that CoQ10 supplementation completely restored SQR
protein levels in P3 patient cell line (102% of controls, P = 1) and
partially increased SQR protein levels in P4 (56% of controls,
P = 0.093; Fig 5A and B). The other enzymes of the H2S oxidation
pathway were unchanged by CoQ10 supplementation (Fig 5A and
C–E). In summary, these data show that severe CoQ10 deficiency
is associated with proportional reduction in SQR, and increased
levels of the enzymes of the downstream pathway. CoQ10
supplementation increases the levels of SQR, without normalizing
the levels of the enzymes of the downstream pathway, suggesting
that these depend on SQR levels, rather than CoQ10 levels.
Inhibition of CoQ10 synthesis by 4-NB treatment in wild-type
fibroblasts and ADCK3 knockdown in HeLa cells recapitulates the
molecular phenotype of CoQ10-deficient patient fibroblasts
To assess whether the molecular abnormalities in the H2S oxidation
pathway observed in patient fibroblasts were caused by CoQ10 defi-
ciency independently from the primary molecular defects, we used
two approaches: (i) We pharmacologically inhibited CoQ10 biosyn-
thesis in wild-type skin fibroblasts with 4-nitrobenzoate (4-NB), an
analogue of 4-hydroxybenzoate (4HB) that specifically inhibits the
activity of COQ2 and causes CoQ10 deficiency (Forsman et al, 2010;
Quinzii et al, 2012), and (ii) we knocked down ADCK3 in HeLa
cells. ADCK3 is an atypical protein kinase, whose mutations cause
CoQ10 deficiency in humans and whose yeast homologue has been
shown to regulate CoQ biosynthesis (Acosta et al, 2016).
Wild-type fibroblasts treated with 4-NB [4 mM] showed 40%
residual CoQ10 levels (CoQ10: 19.35  3.1 ng/mg protein in
A
B C
D E
Figure 4. SQR, TST, ETHE1, and SUOX protein levels in fibroblasts.
A Representative Western blot showing the levels of SQR, TST, ETHE1, and
SUOX proteins in three control (C1–C3) and four patient fibroblast lines
(P1–P4).
B–E Relative levels of proteins normalized to vinculin. Error bars represent
SDs of three experiments. Mann–Whitney U-test. * indicates a value of
P < 0.05, ** indicates a value of P < 0.01, and *** indicates a value of
P < 0.001.
Source data are available online for this figure.
A
B C
D E
Figure 5. SQR, TST, ETHE1, and SUOX protein levels in fibroblasts after
CoQ supplementation.
A Representative Western blots showing the level of SQR, TST, ETHE1, and
SUOX proteins in two control (C1 and C2) and two patient fibroblast
lines (P3 and P4).
B–E Relative levels of proteins normalized to vinculin. Error bars represent
SDs of three experiments. Mann–Whitney U-test. ** indicates a value of
P < 0.01.
Source data are available online for this figure.
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4-NB-treated fibroblasts versus 50.8  14.7 ng/mg protein of
controls; P = 0.02), but not significant reduction in SQR (Fig 6A
and B). These data indicate that (i) SQR may be degraded only in
the presence of severe and constitutive CoQ10 depletion, which
was not the case in 4-NB-treated fibroblasts, and (ii) transcrip-
tional activation of SQR might compensate for the lack of protein
activity and stability.
However, despite the normal SQR levels, we observed a signifi-
cant increase in TST protein in 4-NB-treated cells (164% of controls;
P = 0.02), as we observed in fibroblasts from patients P1 to P4, and
mild, not statistically significant increase in ETHE1 and SUOX (146
and 137% of controls, respectively; Fig 6A and B).
Depletion of ADCK3 in HeLa cells (50% residual ADCK3 levels
compared with controls; P = 0.009; Fig 6C and D) caused CoQ10
deficiency (~50% of controls; CoQ10: 149.7  31.75 ng/mg protein
in ADCK3-depleted cells versus 247.4  11.39 ng/mg protein of
control cells; P = 0.04) and a significant reduction in SQR protein
levels (40% of controls; P = 0.0001; Fig 6C and D). Consistently
with the observations in patient fibroblasts, in ADCK3-depleted
cells, we found also increased levels of TST (164% of controls;
P = 0.038), ETHE1 (129.5% of controls; P = 0.36), and SUOX
(298% of controls; P = 0.007; Fig 6C and D).
In summary, these data confirm that reduction in CoQ10 levels,
≤ 40% of physiological levels, induces SQR depletion, which is
associated with up-regulation of the H2S downstream oxidation
pathway.
mRNA transcript levels of the enzymes of the H2S oxidation
pathway downstream of SQR are increased in
CoQ10-deficient fibroblasts
In order to understand whether changes in protein levels of the
enzymes involved in H2S oxidation pathway observed in CoQ10-
deficient cells are associated with modifications of mRNA transcript
levels, we performed quantitative RT–PCR in fibroblasts from
patients P1–P4, in wild-type fibroblasts treated with 4-NB, and in
ADCK3-depleted cells.
SQR mRNA levels were significantly reduced in fibroblasts from
P1, P3, and P4 (60, 76 and 45% of controls, respectively; P = 0.021,
P = 0.03, and P = 0.004; Fig EV1A). However, we observed an
increase in SQR mRNA in P2 (191%; P = 0.021) compared with
controls (Fig EV1A). This almost twofold transcriptional up-
regulation may explain why this cell line had only partially
decreased SQR protein levels.
We did not find any difference in TST mRNA transcript levels
between patients and control cells again with the exception of P2,
which showed a significant increase in TST mRNA transcript
levels (188% of controls; P = 0.003; Fig EV1B). ETHE1 and SUOX
mRNA transcript levels were significantly increased only in P3
and P4 (185% and 187 of controls, respectively; P = 0.036 and
P = 0.034; Fig EV1C and D), and SUOX mRNA levels were
increased only in P4 (190% of controls, P = 0.004; Fig EV1C
and D).
To assess whether differences in ROS production are responsible
for the alterations in mRNA expression levels of the enzymes of the
H2S oxidation pathway, we performed MitoSoX staining in P3 and
P4. However, fluorescence intensity was comparable between
mutant and control skin fibroblasts (Appendix Fig S3). We previ-
ously excluded increased MitoSoX staining and oxidative stress in
P1 and P2 cultured under the same conditions (Quinzii et al, 2008,
2010; Lopez et al, 2010).
To determine whether exogenous CoQ10 affects transcript levels
of the enzymes of the H2S oxidation pathway, we measured their
mRNA in P3, P4, and controls cultured with 5 lM of CoQ10 for
1 week. We observed a slight increase in SQR mRNA in P3 [from
75% (P = 0.024) to 86% of control (P = 0.072)], which only partly
explains the increase in SQR protein level observed in the same cell
line. Surprisingly, SQR mRNA levels were severely decreased in P4
(from 63 to 19% of control; P = 0.0061) and partially in control cell
lines (63% of control; P = 0.028). In controls, also TST and SUOX
mRNA levels were partially decreased (86 and 82% of untreated;
P = 0.05 and P = 0.007), while ETHE1 transcript levels were
reduced in P4 (from 66 to 36% of control; P = 0.048 and P = 0.004,
respectively; Fig EV2).
Inhibition of CoQ synthesis through 4-NB treatment caused a
significant increase in TST and SUOX mRNA transcript levels (200
and 168% of controls; P = 0.02 and P = 0.04), and showed a trend
toward an increase in SQR and ETHE1 mRNA transcript levels (127
and 158% of controls; P = 0.84 and P = 0.15; Fig EV3A). These
abnormalities became even more evident if the cells were supple-
mented with 4-NB in galactose medium (Fig EV3B).
Depletion of ADCK3 in HeLa cells caused a significant decrease
in SQR mRNA levels (29%; P = 0.009 of controls; Fig EV3C). The
downstream enzymes expression levels were comparable in
ADCK3-depleted and control cells (Fig EV3C).
A B
C D
Figure 6. SQR, TST, ETHE1, and SUOX protein levels in 4-NB-treated
fibroblasts and ADCK3-depleted HeLa cells.
A Representative Western blots showing SQR, TST, ETHE1, and SUOX of two
control fibroblast lines treated with DMSO () or with DMSO + 4-NB (+).
B Quantification of protein levels in fibroblasts treated with 4-NB relative to
control.
C Representative Western blots showing ADCK3, SQR, TST, ETHE1, and SUOX
in two control (EV) and six ADCK3-depleted clones (ADCK3 RNAi).
D Quantification of protein levels in ADCK3-depleted clones (ADCK3 RNAi)
relative to controls (EV).
Data information: Error bars in (B, D) represent SDs of at least three
experiments with different cell lines. Paired t-test in (B). Mann–Whitney U-
test in (D). * indicates a value of P < 0.05, ** indicates a value of P < 0.01, and
*** indicates a value of P < 0.001.
Source data are available online for this figure.
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To confirm that H2S accumulation is caused by SQR reduction
due to CoQ deficiency and to exclude that H2S increase causes
reduction in SQR levels, we supplemented wild-type fibroblasts
for 24 h with 0.5 mM NaHS. These conditions have been previ-
ously shown to be toxic (Di Meo et al, 2011). SQR mRNA and
protein levels were not decreased in treated fibroblasts (Appendix
Fig S4).
In conclusion, these data show that CoQ10 deficiency causes
reduction in SQR at translational level. The increase in the levels of
the other enzymes of the H2S oxidation pathway appears to be a
secondary response at translational level to decreased SQR levels or
activity.
Protein S-sulfhydration is increased in CoQ10-deficient cells
H2S physiologically modifies sulfhydryl groups of some proteins,
modifying their function. To prove that H2S oxidation impair-
ment and consequent H2S accumulation caused by CoQ defi-
ciency increases the levels of protein S-sulfhydration, we
assessed H2S-mediated protein sulfhydration in P1 (~50% resid-
ual CoQ; normal SQR protein levels) and P4 (~15% residual
CoQ; ~26% SQR protein). As expected, we found increased
protein sulfhydration in patient cell lines compared with controls
(Fig 7; Appendix Table S1); however, there was no difference in
the magnitudes of the increases in the two patient cell lines
(1.61- and 1.49-fold increase, respectively, compared with
controls; Fig 7; Appendix Table S1), indicating that in P1,
although SQR protein levels are normal, the partial lack of CoQ
is enough to reduce SQR activity, as shown by the experiment
of SQR-driven respiration.
Severe depletion of SQR in HeLa cells causes down-regulation of
the downstream enzymes of the H2S oxidation pathway
To further prove that the downstream enzymes of the H2S oxidation
pathway are regulated by SQR levels, we transiently knocked down
SQR in HeLa cells. After 24 h of RNA interference, although SQR
mRNA levels were severely reduced (20% of controls; P = 0.024),
the changes in the level of SQR protein (80% of controls, P = 0.07)
were too subtle to affect the levels of the downstream enzymes
(Fig EV4A). However, after 48 h, we observed severe reduction in
SQR mRNA (5% of controls; P = 0.0003) and protein levels (5% of
controls; P = 0.0002; Fig EV4B, D and F), associated with down-
regulation of TST, ETHE1, and SUOX mRNA levels (75, 52, and 76%
of controls; P = 0.1, P = 0.013, and P = 0.057; Fig EV4B, D and F).
In contrast, only TST protein levels were decreased (76% of
controls; P = 0.0005; Fig EV4B and D).
These data indicate that reduction in SQR, below 20% of control
levels, causes transcriptional down-regulation of the enzymes of the
downstream H2S oxidation pathway.
The H2S oxidation pathway is impaired in clinically affected
tissues of Pdss2kd/kd mice
To assess the relationship between CoQ levels and sulfide metabo-
lism in vivo, we measured mRNA and protein levels of the enzymes
involved in H2S oxidation pathway in kidney and brain of Pdss2
kd/kd
mice, which carry a homozygous mutation in Pdss2, a subunit of
the first enzyme of CoQ biosynthesis (Peng et al, 2004). We previ-
ously demonstrated that kidney, the only clinically affected organ of
these animals, had 14% residual CoQ9 (the form of CoQ more
Figure 7. Quantitative analysis of protein sulfhydration in fibroblasts.
Distribution of peptides containing sulfhydrated cysteine residues relative to their H/L ratios as determined by the BTA analysis of cell extracts isolated from C1 and P1 patient
cells (left) and C2 and P4 fibroblasts (right). Values of H/L ratios are plotted against the number of identified peptides. The gray line marks the H/L ratio > 2, consisting of
cysteine-containing peptides in proteins from patient cell lines that exhibited higher reactivity with H2S compared with the respective control. Indicated on the x-axes are
representative sensitive cysteine peptides, which are common between the ones found in the RedoxDB database, and by the BTA assay.
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abundant in mice) concentrations, while brain, which was clinically
unaffected, had 30% residual CoQ9 concentrations (Quinzii et al,
2013). Consistent with our observation in mutant fibroblasts, SQR
protein levels were severely reduced in kidneys of mutant (16% of
controls; P = 0.0001) as compared with control animals (Fig 8A). In
contrast to our observations in fibroblasts, which had increased
TST, ETHE1, and SUOX protein levels, but consistent with the
results in SQR-depleted cells, these proteins were all significantly
decreased in the kidney tissue of Pdss2kd/kd mice (30, 34 and 45%
of controls, respectively; P = 0.0001, P = 0.003, and P = 0.003) as
compared with wild-type mice (Fig 8B–D).
SQR protein levels in brain were almost undetectable in wild-type
mice (Fig 8A), while Pdss2kd/kd mice exhibited a trend toward
increase in SQR protein levels in brain (154% of controls; P = 0.211;
Fig 9A), which was in stark contrast to the situation in the kidney.
Importantly, levels of the other enzymes of the pathway were
comparable with those of control wild-type animals (Fig 9B–D).
We did not observe a reduction in SQR mRNA transcript levels in
kidney of Pdss2kd/kd mice (Fig EV5A). However, as observed in
patient fibroblasts (Fig EV1B) and in fibroblasts treated with 4-NB
(Fig EV3A and B), mRNA transcript levels of the genes encoding the
downstream pathway were increased, although only TST and
ETHE1 mRNA transcript levels increased significantly (200 and
480% of controls; P = 0.012 and P = 0.045; Fig EV5A), suggesting
an attempt of transcriptional up-regulation to compensate for the
reduced protein levels.
The levels of GSH are reduced in clinically affected tissues of
Pdss2kd/kd mice
Intrigued by the observation that both TST and ETHE1 protein
levels, which are involved in glutathione (GSH) regeneration, were
decreased in kidney tissue of Pdss2kd/kd mice, we measured the total
level of GSH in kidney and brain of Pdss2kd/kd mice. GSH levels
were significantly reduced in kidney (17% of controls; P = 0.016),
but not in brain of Pdss2kd/kd mice (Fig 10A and B).
The levels of thiosulfates are reduced in urine of Pdss2kd/kd mice
TST transfers sulfur to GSH, thereby converting it to GSSG. The source
of sulfur is thiosulfate, produced by SQR. To test the hypothesis that
reduced activities of SQR and downstream enzymes would decrease
A
B C
D E
Figure 8. SQR, TST, ETHE1, and SUOX protein levels in the kidney of
Pdss2kd/kd mice.
A Representative Western blots showing the levels of SQR, TST, ETHE1, and
SUOX protein in the kidney of three wild-type (WT) and three mutant
(Mut) mice.
B–E Relative levels of proteins normalized to vinculin. Error bars represent
SDs of nine animals per group. Mann–Whitney U-test. *** indicates a
value of P < 0.001.
Source data are available online for this figure.
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Figure 9. SQR, TST, ETHE1, and SUOX protein levels in brain of Pdss2kd/kd
mice.
A Representative Western blots showing the levels of SQR, TST, ETHE1, and
SUOX protein in the brain of five wild-type (WT) and five mutant (Mut)
mice.
B–E Relative levels of proteins normalized to vinculin. Error bars represent
SDs of five animals per group. Mann–Whitney U-test.
Source data are available online for this figure.
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Figure 10. GSH, thiosulfate, H2S, and acylcarnitines levels in Pdss2
kd/kd mice.
A, B Total GSH amount normalized to protein from kidney (A) and brain (B) of wild-type (WT) and mutant (Mut) mice. Error bars represent SDs of at least three animals
per group.
C, D Thiosulfate levels in urine (C) and plasma (D) normalized to protein amount. Error bars represent SDs of nine animals per group (urine) and six animals per group (plasma).
E, F H2S amount normalized to tissue from kidney (E) and brain (F). Error bars represent SDs of seven to eight animals per group.
G Acylcarnitine C4, C5, and C6 levels from plasma, normalized to volume. Error bars represent SDs of five wild-type and three mutant mice.
Data information: Mann–Whitney U-test. * indicates a value of P < 0.05.
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the production of thiosulfate, we measured thiosulfate in urine and
plasma of Pdss2kd/kd mice. We found that the amount of thiosulfate
was significantly reduced in the urine (21% of controls; P = 0.02), and
mildly, although not significantly reduced in plasma (60% of controls)
of Pdss2kd/kd as compared with wild-type mice (Fig 10C and D).
Levels of H2S are increased in clinically affected tissues of
Pdss2kd/kd mice
To investigate whether CoQ deficiency might cause an accumulation
of H2S in vivo, we measured H2S levels in kidney and brain of
Pdss2kd/kd and wild-type mice and found them significantly
increased only in kidney of the Pdss2kd/kd animals (133% of
controls; P = 0.04; Fig 10E). These data suggest that, as expected,
down-regulation of the H2S catabolic pathway leads to H2S accumu-
lation in the kidney.
H2S accumulation in Pdss2
kd/kd mice causes a defect of
short-chain fatty acid oxidation
To assess toxic effects of H2S accumulation in Pdss2
kd/kd mice, we
determined COX activity in kidney and brain as well as the acylcar-
nitine profile in plasma of Pdss2kd/kd and wild-type mice. COX activ-
ity, normalized to protein amount and to CS and SDH activities,
indices of mitochondrial mass, was not reduced in any tissue
analyzed. However, C4 and C6 levels were significantly increased,
and C5 was moderately increased in blood of Pdss2kd/kd mice (236
and 228%, and 167% of controls respectively; P = 0.036, P = 0.035,
and P = 0.14; Fig 10G; Appendix Table S2). These data suggest that
H2S accumulation causes inhibition of short-chain acyl-CoA dehy-
drogenase (SCAD) and a subsequent defect of short-chain fatty acid
oxidation.
Discussion
Here, we have addressed the role of an impairment of H2S oxidation
in the pathogenesis of CoQ deficiency. We demonstrated that CoQ-
deficient fibroblasts carrying mutations in different COQ genes have
decreased SQR-driven respiration, which is associated with variably
reduced SQR steady-state levels, depending on the severity of CoQ
deficiency, and subsequent compensatory up-regulation of the levels
of the downstream proteins of the pathway. We hypothesize that if
the levels of CoQ are very low, SQR activity is decreased and SQR
becomes unstable and is probably degraded. Partial reduction in
SQR and/or its activity leads to up-regulation of the enzymes of the
downstream pathway (TST, ETHE1, and SUOX), which is more
evident at the translational than at transcriptional level. The molec-
ular abnormalities observed in COQ-mutant fibroblasts are due to
reduced CoQ levels, because they can be rescued by CoQ supple-
mentation and are partially recapitulated by pharmacological inhibi-
tion of CoQ biosynthesis via 4-NB in wild-type fibroblasts and by
ADCK3 depletion in HeLa cells. 4-NB is an analogue of 4-HB and
inhibitor of 4-para-hydroxybenzoate:polyprenyl transferase (COQ2;
Forsman et al, 2010). We previously showed that 4-NB at a concen-
tration of 4 mM causes a CoQ deficiency of ~40% and consequent
reduced ATP and ATP/ADP levels, increased ROS and oxidative
stress resulting in cell death (Quinzii et al, 2012). Here, we found
that the same dose of 4-NB is associated with normal levels of SQR
protein. We hypothesize that the decrease in CoQ levels is not
severe enough to cause protein instability, or that in fibroblasts SQR
is degraded only if CoQ deficiency is chronic, and that the limited
timeframe of pharmacologic inhibition of CoQ biosynthesis might
decrease SQR activity, but not its protein levels. Consistent with the
first possibility is our observation that COQ-mutant fibroblasts with
more severe CoQ deficiency (P3 and P4) have the lowest levels of
SQR. P2 and fibroblasts treated with 4-NB show transcriptional up-
regulation of SQR mRNA, not evident in the other cell lines. We
cannot explain why the response of the H2S oxidation pathway to
CoQ deficiency differs among patient cell lines at transcriptional
levels. However, the effect of CoQ synthesis inhibition on SQR
mRNA levels was striking, suggesting that changes in CoQ levels
modulate gene expression, possibly through this antioxidant func-
tion. Indeed, a role of CoQ in several biological processes, such as
lipid metabolism, inflammation, and cell signaling through regula-
tion of genes expression, has been previously proposed (Schmelzer
et al, 2008; Fischer et al, 2016). The level of the enzymes of the
pathway downstream SQR appears to be regulated by SQR activity
and/or level: Partial SQR depletion as observed in patient fibro-
blasts, 4-NB-treated wild-type fibroblasts, and ADCK3-depleted HeLa
cells causes up-regulation of the other enzymes, while severe SQR
depletion shuts down the pathway, suggesting a mechanism of regu-
lation of the pathway downstream SQR possibly dependent on the
availability of catabolites generated by SQR activity. Although our
data suggest a tight regulation at both transcriptional and transla-
tional level, this regulatory mechanism needs further investigation.
As a consequence of sulfide accumulation, COQ-mutant fibrob-
lasts have increased protein S-sulfhydration. Although we observed
a correlation between degree of CoQ deficiency and SQR-driven
respiration defect, these changes were not correlated with the
magnitude of protein sulfhydration increase. This may be due to (i)
experimental conditions, since SQR-driven respiration is measured
adding excess of NaHS as substrate, while protein sulfhydration was
measured under physiological conditions, or (ii) presence of other
compensatory mechanisms regulating H2S levels, for example, effect
on the upstream H2S biosynthesis pathway, depending on CoQ
levels or genetic background of the fibroblasts. Regardless, CoQ
deficiency clearly causes disregulation of an important post-
translational modification, which may affect multiple physiological
processes (Mustafa et al, 2009; Paul & Snyder, 2012).
The observation that NaHS supplementation in wild-type fibro-
blasts does not cause reduction in mRNA and protein SQR levels
confirms that lack of CoQ and SQR causes sulfide accumulation, and
not vice versa.
Interestingly, we found normal levels of SQR and an increase in
protein levels for TST, ETHE1, and SUOX in brain of Pdss2kd/kd mice,
which harbor a spontaneous mutation in the gene encoding the
subunit 2 of polyprenyl-diphosphate synthase (Pdss2), the first
enzyme of the CoQ biosynthetic pathway. Homozygous Pdss2kd/kd
mice are apparently healthy for the first 8 weeks of life, but from
12 weeks of age onward, histological analysis of the kidney (which
has only 15% residual CoQ) reveals a mononuclear cell infiltrate and
tubular dilatation. Adult Pdss2kd/kd mice develop a typical nephrotic
syndrome, leading to kidney failure (Peng et al, 2004; Madaio et al,
2005). In brain, which has ~30% residual CoQ concentrations and
does not show any clinical phenotype, SQR was detectable only in
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mutant mice, and the downstream H2S oxidation pathway was
normal. It is noteworthy that we detected SQR in brain of mutant
and not wild-type animals, since although SQR mRNA has been
reported to be present in brain, the presence of SQR protein in brain
is still under debate (Ackermann et al, 2011; Linden et al, 2012). In
contrast, in kidney of Pdss2kd/kd mice, we did not find an up-
regulation of the sulfide oxidation pathway, but rather decreases in
all the enzymes of the pathway. Moreover, we observed reduced
GSH in kidney and very low levels of thiosulfate in the urine of
Pdss2kd/kd mice, suggesting a shutdown of the oxidation pathway, as
observed in SQR-depleted HeLa cells cultured for 48 h.
As a consequence of the shutdown of the H2S catabolic pathway,
we observed a mild accumulation of H2S in mutant mice kidney
compared with controls. This quantification may be inaccurate,
because H2S is extremely volatile and therefore difficult to measure
in tissues (Vitvitsky et al, 2012). The only moderate increase in H2S
concentrations we observed may explain the absence of COX defi-
ciency in the affected tissues of the Pdss2kd/kd mice (Quinzii et al,
2012). Although COX inhibition is considered the primary mecha-
nism of H2S toxicity (Nicholls & Kim, 1982), it is possible that in
CoQ deficiency, where SQR activity is reduced but not completely
absent, H2S levels are not high enough to suppress COX activity in
contrast to ethylmalonic aciduria, which presents with a much more
severe phenotype and COX deficiency in patients (Tiranti et al,
2009). Furthermore, it is important to note that the ethylmalonic
aciduria mouse model shows normal COX activity and level in
kidney and liver, in spite of high thiosulfate and H2S concentrations.
This may reflect the presence of tissue-specific alternative metabolic
pathways for H2S detoxification, or different buffering mechanisms
(Tiranti et al, 2009). Nevertheless, other mechanisms of H2S toxic-
ity, including inhibition of short-chain fatty acid oxidation, GSH
depletion (Truong et al, 2006), and the ability of H2S to generate
ROS (Bouillaud & Blachier, 2011), may play a role in the pathogene-
sis of CoQ deficiency and EE-deficient mice. We previously demon-
strated increased ROS production and oxidative stress in kidney
tissue of Pdss2kd/kd mice (Quinzii et al, 2013). The role of oxidative
stress in the pathogenesis of CoQ deficiency is supported by the
observation of CoQ deficiency and oxidative stress in the brain of
Coq9-mutant mice (Garcia-Corzo et al, 2013). Moreover, in COQ-
mutant fibroblasts, and in wild-type fibroblasts treated with 4-NB,
we showed that reduced cell viability correlated with increased ROS
production and oxidative stress (Lopez et al, 2010; Quinzii et al,
2010, 2012). We also observed in one COQ-mutant cell line (P2 in
this work) a trend toward a decrease in total GSH content accompa-
nied by a slight decrease in the activities of the glutathione enzymes
GPx and GRd (Quinzii et al, 2008). Therefore, it is tempting to spec-
ulate that tissue-specific abnormalities of H2S metabolism may
contribute to oxidative stress in CoQ deficiency through alteration of
the glutathione system. For example, H2S autoxidation could
produce reactive sulfur and oxygen radical causing GSH depletion
(Truong et al, 2006), or synthesis of GSH could be down-regulated
to balance the increase in GSH caused by decrease in TST. However,
the causes of GSH reduction can be independent of H2S oxidation
impairment. Since CoQ is an antioxidant, both via direct prevention
of lipid peroxidation and indirect regeneration of other antioxidants
such as vitamins C and E, as well as an electron carrier in the mito-
chondrial respiratory chain, lack of CoQ may cause an increase in
ROS production and oxidative stress because antioxidant defenses
are reduced and electron transport in the respiratory chain is
impaired. Therefore, chronic oxidative stress due to the lack of CoQ
could be responsible for depletion of antioxidant defenses, including
GSH. Importantly, Luna-Sa´nchez et al (2017) showed reduced GSH
levels in brain of Coq9-mutant mice. However, they also observed
that SQR-depleted cells have GSH levels comparable to controls,
supporting the hypothesis that reduction of GSH is independent of
SQR levels, or is a tissue- or cell-specific effect of low SQR (Luna-
Sa´nchez et al, 2017).
We cannot discern between the single factors in the overall
increase in oxidative stress in states of CoQ deficiency. ROS have
been shown to have a role in the pathogenesis of nephrotic
syndrome (Greenbaum et al, 2012; Emma et al, 2016); however, the
relationship between oxidative stress and hydrogen sulfides in renal
pathology is controversial. Although most of the literature supports
the notion that hydrogen sulfide protects against oxidative stress
and thus generally also against renal disease (Koning et al, 2015;
Lobb et al, 2015), some recent studies suggest that treatment with
the CSE inhibitor propargylglycine (PAG) inhibits endogenous H2S
production and increases antioxidant enzyme expression while
significantly improving renal function reducing renal damage,
fibrosis, and inflammation. Another study demonstrated that PAG-
treated animals exhibited significantly improved renal function and
decreased renal necrosis as well as decreased ROS production,
oxidative stress, and caspase activation following gentamicin treat-
ment (Francescato et al, 2012).
We postulate that the discrepancy in levels of SQR between
human fibroblasts and mouse kidney is mostly tissue related. Tissue
specificity is typical of human and murine mitochondrial disorders,
and fibroblasts are not clinically affected. We previously observed
that Pdss2-mutant fibroblasts do not show the detrimental effects of
CoQ deficiency observed in Pdss2-mutant mice kidney. The molecu-
lar and biochemical abnormalities observed in patient fibroblasts
reflect more severe abnormalities or a selective vulnerability to the
effects of CoQ deficiency of the kidney, which is often clinically
affected in CoQ deficiency, independently of the molecular defect.
In conclusion, we demonstrate that impairment of hydrogen sul-
fide oxidation may play a synergistic role with CoQ deficiency in the
pathogenesis of nephrotic syndrome, one of the most common
phenotypes of human CoQ deficiency through generation of addi-
tional oxidative stress. Our results provide insight into a novel
disease mechanism and into the unresolved mechanisms responsi-
ble for the efficacy of CoQ10 treatment in nephrotic syndrome (Saiki
et al, 2008; Emma et al, 2016).
Furthermore, we describe for the first time a defect of fatty acid
oxidation to be associated with primary CoQ deficiency. This obser-
vation deserves further confirmation in human patients, because it
might explain some of the clinical features present in CoQ deficiency
with a severe early-onset multi-organ phenotype, and has clear
therapeutic implications.
Materials and Methods
Cell culture
All experiments were performed in human skin fibroblasts from at
least five controls and four CoQ10-deficient patients (Table 1), unless
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specified otherwise. Experiments were performed in replicate. Cells
were grown in Dulbecco’s minimum essential medium (DMEM)
supplemented with 10% fetal bovine serum (FBS), 5 ml MEM vita-
mins, 5 ml MEM non-essential amino acids, 1 ml fungizone, and
5 ml penicillin–streptomycin, at 37°C in 5% CO2 atmosphere.
In order to assess the effects of pharmacological inhibition of
CoQ biosynthesis on sulfide metabolism, we incubated control skin
fibroblasts with 4-nitrobenzoate (4-NB) for 6 days. DMEM supple-
mented with 4 mM 4-NB or 4 mM DMSO was added to the cells at
days 1, 3, and 5, and cells were collected at day 7. To assess the
effects of forcing energy production through oxidative phosphoryla-
tion on sulfide metabolism, we performed the same experiments
also in glucose-free medium, by adding 4-NB to RPMI 1640 glucose-
free medium supplemented with galactose, 10% regular FBS,
25 mM HEPES, 1.5 mM Glutamax, 25 mM galactose, 1 ml fungi-
zone, and 5 ml penicillin–streptomycin (Quinzii et al, 2012).
To assess the effects of CoQ supplementation on the H2S oxida-
tion pathway enzymes protein and mRNA levels, we incubated skin
fibroblasts with 5 lm CoQ10 (Hydro Q Sorb Powder, Tishcon Corp.,
USA) for 1 week, adding fresh medium supplemented with CoQ10
four times.
In order to exclude that H2S accumulation leads to decrease in
SQR levels, we supplemented wild-type fibroblasts with 0.5 mM
NaHS for 24 h as previously described (Di Meo et al, 2011).
Animal care
B6/Pdss2kd/kd mice were purchased from Jackson laboratory.
Pdss2kd/kd mice harbor a spontaneous mutation in the gene encod-
ing the subunit 2 of polyprenyl-diphosphate synthase (Pdss2) and
their phenotype was previously described (Peng et al, 2004; Quinzii
et al, 2013). All experiments were performed according to a protocol
approved by the Institutional Animal Care and Use Committee of
the Columbia University Medical Center, and were consistent with
the National Institutes of Health Guide for the Care and Use of Labo-
ratory Animals. Mice were housed and bred according to the inter-
national standard conditions, with a 12-h light/12-h dark cycle and
free access to food and water.
Urine was collected at 5–6 months of age by manually restrain-
ing the mice and promptly stored at 80°C. Mutant and control
animals were euthanized by rapid carbon dioxide narcosis followed
by cervical dislocation at end stage of the disease (6 months). Blood
was extracted from the heart and collected in tubes with EDTA.
Plasma was obtained from blood by centrifugation at 4°C at 800 rcf
for 15 min and kept at 80°C. Brain and kidneys were quickly
removed and frozen in the liquid phase of isopentane, pre-cooled
toward its freezing point (80°C) with dry ice. Experiments were
performed in 5–10 mice for each group.
Determination of CoQ10 levels in fibroblasts
Control and mutant skin fibroblasts (P1–P4) were grown until con-
fluence, collected and washed with 1× PBS, and the pellets were
stored at 80°C. CoQ10 was isolated with the hexane/ethanol 5:2
extraction technique. The combined hexane extract was dried under
slow N2 gas flow and then resuspended in 1-propanol. CoQ10 levels
were determined by high-performance liquid chromatography
(HPLC) on a reverse-phase Symmetry C18 3.5 mm, 4.6 × 150 mm
column (Waters), using a mobile phase consisting of methanol,
ethanol, 2-propanol, acetic acid (500:500:15:15), and 50 mM
sodium acetate at a flow rate of 0.9 ml/min. The electrochemical
detection system consisted of an ESA Coulochem III with a guard
cell (upstream of the injector) at +900 mV, conditioning cell at
600 mV (downstream of the column), followed by the analytical cell
at +500 mV. The CoQ10 concentration was estimated by comparison
of the peak area with those of standard solutions of known concen-
trations. Levels of CoQ10 in P5 were measured as described previ-
ously (Brea-Calvo et al, 2015).
Oxygen consumption in fibroblasts
Oxygen consumption from 3 × 10E6 cells permeabilized by 80 lg/
ml digitonin was monitored with a Clark-type electrode (Oxygraph
Hansatech Inst., Norfolk, United Kingdom) at 37°C in a respiration
buffer (pH 7.4) containing 300 mM mannitol, 10 mM KCl, 5 mM
MgCl2, 10 mM KH2PO4, enriched with 0.1% BSA. The maximum
respiratory capacity was measured by adding 4 lM of the uncoupler
carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP).
Rotenone (1 lM, complex I inhibitor), antimycin A (1 lM, complex
III inhibitor), and Na-cyanide (200 lM, complex IV inhibitor)
concentrations were set to reach full respiratory inhibition (data not
shown). The substrate concentrations were as follows: for SQR-
driven respiration: NaHS, 60 lM; for complex II-driven respiration:
ADP, 1 mM and succinate, 10 mM; for complex IV-driven respira-
tion: TMPD + ascorbate, 300 lM and 6 mM, respectively. NaHS
concentration was set to prevent complex IV inhibition. All
measurements were corrected by subtracting the residual oxygen
consumption present after full inhibition of the respiratory chain.
In recovery experiments, cells were cultured for 1 week in the
presence of 5 lM CoQ10 (Skatto, Chiesi Farmaceutici, Italy).
Sulfide metabolism pathway studies in fibroblasts and
mouse tissues
Gene expression by real-time PCR
Total RNA from skin fibroblasts and mouse tissues was extracted
using the TRIzol method and quantified by NanoDrop. RNA was
stored at 80°C. RNA samples were digested with DNase before
reverse trascription (RT). RT to obtain single-strand cDNA was
executed with 0.5–1.0 lg of RNA and the Vilo2 kit (Sigma Aldrich).
To determine mRNA of the SQRDL, TST, ETHE1, and SUOX
genes in cells and in mouse tissues, quantitative RT–PCR was
performed using TaqMan Assays with the following Applied
Biosystems probes: SQRDL, Hs01126963_m1 for humans,
Mm00502443_m1 for mouse; TST, Hs00361812_m1 humans,
Mm01195231_m1 for mouse; SUOX, Hs04183429_m1 for humans,
Mm00620388_g1 for mouse; ETHE1, Hs00204752_m1 for humans,
Mm00480916_m1 for mouse. Expression of the target genes was
calculated by DDCT method and normalized to the expression of
GAPDH (#402869 for humans, #4308313 for mouse). The experi-
ments were executed in technical triplicates and repeated with dif-
ferent biological replicates at least three times.
Determination of protein steady-state levels by immunoblotting
To measure the steady-state protein levels of the enzymes known to
be involved in sulfide metabolism, we performed Western blots.
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Proteins were extracted from cell pellets by sonication and from
mouse tissues by mechanical homogenization in lysis buffer (50 nM
Tris–HCl, 150 mM NaCl, 1 mM EDTA). To prevent protein degrada-
tion, a protease inhibitor cocktail (Complete Mini, EDTA-free,
11836170001, Roche) was added to the protein extract and the
samples were kept at 80°C. Cell lysates were quantitated for total
protein content using the Bradford system (ThermoScience) and
analyzed by electrophoresis in a 12–15% PAGE gel or Novex 10–
20% Glycine Gel (EC61355, Invitrogen) loading 10/40 lg of protein
for sample. After electrophoresis, proteins were transferred to a PVC
transfer membrane (IPFL00010, Immobilon-FL). Membranes were
blocked in PBT with 2–5% milk or 2% BSA before incubation with
the following antibodies: rabbit anti-SQR (1:1,000, ab118772 Abcam
for mouse; 1:1,000, 17256-1-AP Proteintech for humans); rabbit
anti-TST (1:1,000, ab155320, Abcam for mouse; 1:1,000, 16311-1-
AP Proteintech for humans); mouse anti-SUOX (1:1,000, ab57852,
Abcam); rabbit anti-ETHE1 (1:1,000, Abcam ab154041); rabbit anti-
ADCK3/CABC1 (1:1,000, Thermo Scientific, Pierce, PA5-13906)
mouse anti-vinculin (1:5,000, Abcam ab18058) for both mouse and
humans; secondary rabbit and mouse HRP (1:2,000, Sigma A9044
and A0545). Protein bands were visualized by chemiluminescence,
using ECL reagents (GE Healthcare). Intensity of the bands was
quantified with ImageJ (NIH).
Generation of cells expressing shRNA
HeLa cells were cultured in DMEM with 10% FBS until 70–80%
confluence. Transfections with scramble shRNA-pLKO plasmid
(used as control) or ADCK3-specific TRC shRNA-pLKO plasmid
construct (SHCLNG-NM_020247 MISSION shRNA Bacterial Glyc-
erol Stock; Sigma Aldrich) were mediated by Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions. After 5 h
of transfection, cells were selected with puromycin/neomycin in
DMEM 2% FBS and transfected clones expanded separately with
DMEM 10% FBS.
Transient knockdown of SQR in HeLa cells was obtained incubat-
ing cells for 24 and 48 h in OptiMEM medium supplemented with
5 ml MEM vitamins and 5 ml MEM non-essential amino acids,
25 pmol of SQRDL Silencer Select Validated siRNA (Ambion
4390824), and Lipofectamine 2000.
Protein sulfhydration studies
Fibroblasts of two different control lines (C1 and C2) and two dif-
ferent patient cell lines (P1 and P4) were grown in duplicate, and
individually, lysate was then clarified by centrifugation at 4°C.
Protein concentrations were determined by the BCA assay. Equal
amount (1.2 mg) of proteins from each sample was incubated with
200 lM NM-biotin for 30 min with occasionally gentle mixing at
room temperature, and subsequently precipitated by cold acetone.
After centrifugation, pellets of precipitated proteins from each
sample were washed individually with the cold acetone twice and
then suspended in denaturation buffer containing urea. The dena-
tured, biotinylated proteins were then diluted with 10 volumes of
the suspension buffer and incubated with modified porcine trypsin
with mixing for 18 h at 30°C. After the digestion, trypsin was
inactivated by incubation at 95°C for 10 min; then, four reaction
mixtures (C1, C2, P1, and P4) were mixed separately with the
streptavidin-conjugated agarose beads and incubated at 4°C for 18 h
following extensive washes in the presence of low concentration of
SDS. Peptides from each column were eluted individually with reduc-
ing agent after 25-min incubation at room temperature. Free -SH
groups from two control fibroblasts (C1 and C2) were alkylated sepa-
rately by NEM (light), whereas deuterium NEM (heavy) was used to
label the patient samples (P1 and P4). After the labeling step, excess
of DTT was supplemented into the reaction mixtures, then incubated
for 25 min at room temperature. The labeled peptides from the C1
and P1 were combined to form one pair sample, whereas the C2 was
pooled with P4. Each pair peptide sample was concentrated and
desalted with a C-18 column for LC-MS/MS analysis. The detailed
descriptions of peptide identification and quantification by LC/MS
were carried out as described in Gao et al (2015).
GSH measurement in mouse tissues
The level of total GSH (T-GSH) was measured according to the
protocol described in Quinzii et al (2008). Briefly, frozen tissue
homogenates were resuspended in 1,000 ll of 6% metaphosphoric
acid, vortexed, incubated at room temperature for 10 min, and
centrifuged at 15,700 g for 10 min at 4°C. Pellets were stored at
80°C for protein determination, and the supernatants were used
to measure GSH. One hundred ll of sample, 750 ll of phosphate
buffer, 50 ll of 10 mM DTNB, and 80 ll of 5 mM NADPH were
added to a 1-ml cuvette. After a 3-min equilibration period at
30°C, 20 ll (1.35 U) of GRd was added, and the change in absorp-
tion over time was measured for additional 3 min. Absolute
concentrations were determined using a standard curve of GSH
(from 0.5 to 20 lg/ml prepared in 6% metaphosphoric acid and
diluted in phosphate buffer). T-GSH concentration was expressed
in nmol/mg protein.
Thiosulfate measurements in mice
Thiosulfate concentration was measured in plasma and urine
collected from mice as previously described (Vo¨lkel & Grieshaber,
1992). Briefly, 2.9 mM monobromobimane was added to both urine
and serum samples. The fluorescent products were separated by
HPLC with a gradient pump and an increasing gradient of methanol,
using a LiChrospher 60 RP-select B, 125-4 (5-lm) column (MERCK,
Darmstadt, Germany). Fluorescence emission at 480 nm was
detected online after excitation at 380 nm.
H2S measurement in mouse tissues
H2S levels were measured by precipitation of H2S with zinc acetate
followed by quantitation with methylene blue as previously
described (Gilboa-Garber, 1971; Ang et al, 2012).
Statistical analysis
In order to compare results of CoQ, thiosulfate, GSH, and acylcar-
nitine measurement, Western blots, and quantitative PCR in cells
and animal tissues, the Mann–Whitney non-parametric U-test was
used, unless specified otherwise. For fibroblast 4-NB supplementa-
tion studies, a paired t-test was used. To compare determination of
SQR-driven respiration and complex IV activity in fibroblasts, a
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two-tailed Student’s t-test was used. For statistical analysis,
GraphPad Prism v5 and Microsoft Excel were used. Data are
expressed as mean  SD of at least three experiments for group. A
value of P < 0.05 was considered to be statistically significant.
* indicates a value of P < 0.05, ** indicates a value of P < 0.01, and
*** indicates a value of P < 0.001.
Expanded View for this article is available online.
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